战略性投入叠加减值计提，东软集团2025年预亏3至3.7亿元

Core Viewpoint - The company, Neusoft Group, is forecasting a net loss for the year 2025, with expected net profit attributable to shareholders ranging from -370 million to -300 million yuan, compared to a profit of 63 million yuan in the same period last year [2][3] Group 1: Financial Performance - The anticipated net profit excluding non-recurring gains and losses is projected to be between -430 million and -360 million yuan [2] - The company experienced a slowdown in revenue growth due to macroeconomic fluctuations, phase adjustments in industry demand, and intense market competition [3] Group 2: Cost and Investment Factors - Costs and expenses have increased year-on-year, primarily due to higher implementation costs from project execution difficulties and increased R&D investments in AI and data value realization [3] - The company is undergoing organizational and business transformations, which, while temporarily increasing costs, aim to enhance organizational efficiency and innovation for long-term growth [3] Group 3: Impact of Strategic Business Segments - Innovative business segments in "big health" and "big automotive," including subsidiaries like Neusoft Medical and Xikang, are expected to negatively impact the net profit and net profit after deducting non-recurring items for the year [3] - The company has conducted impairment tests on long-term equity investments and made provisions for asset impairment, further negatively affecting profits [3]